Is marksans Pharma a good stock?
1. Is Marksans Pharma Ltd a good quality company? Past 10 year’s financial track record analysis by Moneyworks4me indicates that Marksans Pharma Ltd is a average quality company.
Table of Contents
What is the target of Marksans Pharma?
| Date | Stock | Target |
|---|---|---|
| 14 Oct 2021 | Marksans Pharma Ltd. | 87.00 |
| 11 Jun 2018 | Marksans Pharma Ltd. | 31.00 |
| 11 Jun 2018 | Marksans Pharma Ltd. | 31.00 |
| 19 Feb 2018 | Marksans Pharma Ltd. | 55.00 |
Will marksans increase share price?
Marksans Pharma Ltd . quote is equal to 49.200 INR at 2022-07-16. Based on our forecasts, a long-term increase is expected, the “Marksans Pharma Ltd” stock price prognosis for 2027-07-13 is 126.161 INR. With a 5-year investment, the revenue is expected to be around +156.42%.
What does marksans Pharma produce?
Formulation– This division is engaged in manufacturing of tablets, non–sterile liquids, ointments and powder products. The company owns one of the biggest manufacturing facility for soft gelatin in Asia . The company’s manufacturing plants are located at Goa and UK .
Which Pharma share is best to buy?
Pharma Picks Its India-centric picks are IPCA Laboratories, Ajanta Pharma and JB Chemicals & Pharmaceuticals. Its top picks in the US generics space includes Cipla and Dr Reddy’s Laboratories. In the CRAMS space, which Elara calls a secular story, it likes Gland Pharma and Suven Pharmaceuticals.
Is Marksans Pharma debt free?
What Is Marksans Pharma’s Net Debt? The image below, which you can click on for greater detail, shows that at March 2019 Marksans Pharma had debt of ₹1.31b, up from ₹1.17b in one year. However, because it has a cash reserve of ₹335.4m, its net debt is less, at about ₹972.8m.
Is marksans Pharma Debt Free?
Who is the owner of Marksans Pharma?
Mark B. SaldanhaMarksans Pharma / CEO
Who owns marksans Pharma?
Promoter and Managing Director. Mr. Mark Saldanha is the Chairman and Managing Director of Marksans. He set out with a vision to create a global pharmaceutical company.
Is urja global debt free?
Company is virtually debt free.
Who is owner of Glenmark?
Glenn Mario Saldanha (2001–)Glenmark Pharmaceuticals / CEO
Which Pharma stock is best?
7 pharma stocks that may deliver 20-50% returns. Do you own any?
- Pharma Picks.
- Suven: Commercialisation of new molecules on cards.
- Gland Pharma: Biologics, China foray key drivers.
- Dr Reddy’s Labs: Prospects improving.
- Cipla: Earnings sustainable.
- JB Chemicals: Widening wings in India.
Which Pharma stock is best for long term investment?
Cipla Limited is an India-based company that is primarily engaged in the business of pharmaceuticals and is one of the Best Pharma Stocks to Buy in India for Long Term.
Can I buy urja Global shares?
Direct investment: You can buy URJA GLOBAL LIMITED (URJA) shares by opening a Demat account with Angel One. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to URJA GLOBAL LIMITED (URJA) shares.